Related Experiment Video
Updated: Jan 28, 2026

Effect of Bending on the Electrical Characteristics of Flexible Organic Single Crystal-based Field-effect Transistors
Published on: November 7, 2016
Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center
Marie Nakano1, Kazunori Karasawa2, Takahito Moriyama1
1Department of Medicine, Kidney Center, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Background:
Recently, a new classification has been established for membranoproliferative glomerulonephritis (MPGN). However, the effect of the new classification on MPGN treatment is not fully understood.
Methods:
We conducted a retrospective study of 87 patients with biopsies diagnosed as MPGN. We reclassified 87 MPGN patients diagnosed between 1977 and 2014 at our hospital, according to the new classification, and analyzed both primary immune complex (IC)- and Alternative pathway (AP)-mediated MPGN [corrected] in terms of clinicopathological features, treatment, and renal prognosis.
Results:
Proteinuria was abundant in the IC-mediated MPGN group (p = 0.0063), and the serum albumin level was significantly lower in the IC-mediated MPGN group (p = 0.0186). The serum C3 value was significantly lower in the CP-mediated MPGN group (p = 0.0317). Serum CH50 values were also lower in the CP-mediated MPGN group (p = 0.0404). However, glomerular deposition of C3 showed no significant differences in immunofluorescence findings. The 148.6-month renal survival rate was similar in both groups (p = 0.445).
Conclusion:
These results suggested no significant differences in complement activation of the solid phase in local glomeruli and therefore equivalent in renal prognosis [corrected].
Insights
The new classification of membranoproliferative glomerulonephritis (MPGN) shows no difference in renal prognosis between immune complex (IC)-mediated and alternative pathway (AP)-mediated MPGN. Treatment outcomes remain similar for both MPGN types.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- A new classification for membranoproliferative glomerulonephritis (MPGN) has been proposed.
- The impact of this new classification on MPGN treatment strategies and patient outcomes requires further investigation.
Purpose of the Study:
- To reclassify MPGN patients based on the new criteria.
- To analyze clinicopathological features, treatment responses, and renal prognosis in immune complex (IC)-mediated and alternative pathway (AP)-mediated MPGN.
Main Methods:
- Retrospective analysis of 87 MPGN patients diagnosed between 1977 and 2014.
- Reclassification of MPGN cases according to the new immune complex (IC) and alternative pathway (AP) classification.
- Comparison of clinicopathological data, treatment, and renal survival rates between the two MPGN subtypes.
Main Results:
- Proteinuria and lower serum albumin were noted in IC-mediated MPGN.
- Lower serum C3 and CH50 values were observed in AP-mediated MPGN.
- No significant difference in glomerular C3 deposition or renal survival rates between the groups.
Conclusions:
- The study suggests no significant difference in complement activation within glomeruli between IC-mediated and AP-mediated MPGN.
- Renal prognosis is equivalent for both MPGN subtypes under the new classification.
- The findings support similar treatment approaches for both MPGN classifications.
Related Concept Videos
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...
Characteristics of Life
Classification of Titrimetric Analysis Based on Reaction Types
Titrations between an acid and a base lead to neutralization reactions that form...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Center of Gravity
Center of Gravity
To determine its location, the principle of moments can be utilized by dividing the object into...

